2008 Fiscal Year Final Research Report
Analysis of signaling pathways in peritoneal dissemination of ovarian cancer, which leads to investigation for their suppressor reagents.
Project/Area Number |
19390426
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Obstetrics and gynecology
|
Research Institution | Kyoto University |
Principal Investigator |
KONISHI Ikuo Kyoto University, 医学研究科, 教授 (90192062)
|
Co-Investigator(Kenkyū-buntansha) |
MANDAI Masaki 京都大学, 医学研究科, 講師 (80283597)
MATSUMURA Noriomi 京都大学, 医学研究科, 助教 (20452336)
BABA Tsukasa 京都大学, 医学研究科, 助教 (60508240)
ITO Kazuko 信州大学, 医学部・附属病院, 講師 (40303458)
HORIUCHI Akiko 信州大学, 医学部, 助教 (80334895)
OSADA Ryosuke 信州大学, 医学部・附属病院, 助教 (80418722)
OHIRA Satoshi 信州大学, 医学部・附属病院, 助教 (90397315)
|
Project Period (FY) |
2007 – 2008
|
Keywords | 卵巣癌 / 播種性転移 / エピジェネティックス / シグナル伝達 / マイクロアレイ / 低分子化合物 |
Research Abstract |
卵巣癌の微小環境によるシグナル分子のエピジェネティックな変化に伴い、HIF-SNAIL-E-cadherin 経路、S100A4-RhoA 経路、Hedgehog 経路、さらにTGFβ経路の活性化が、卵巣癌細胞の播種性転移を促進させることを明らかとした。さらにRhoA、Hedgehog、TGFβの各シグナル経路を阻害する低分子化合物は、卵巣癌播種性転移の治療薬となりうることを明らかにした。
|
Research Products
(29 results)
-
-
-
-
-
[Journal Article] Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinica lOncology Group Study JCOG02062009
Author(s)
Onda T, Kobayashi H, Nakanishi T, Hatae M, Iwasaka T, Konishi I, Shibata T, Fukuda H, Kamura T, Yoshikawa H.
-
Journal Title
Gynecol Oncol 113
Pages: 57-62
Peer Reviewed
-
-
-
-
-
[Journal Article] Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells2009
Author(s)
Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK.
-
Journal Title
Oncogene. 28
Pages: 209-18
Peer Reviewed
-
[Journal Article] Yin yang 1 modulates taxane response in epithelial ovarian cancer2009
Author(s)
Matsumura N, Huang Z, Baba T, Lee PS, Barnett JC, Mori S, Chang JT, Kuo WL, Gusberg AH, Whitaker RS, Gray JW, Fujii S, Berchuck A, Murphy SK.
-
Journal Title
Mol Cancer Res 7
Pages: 210-20
Peer Reviewed
-
[Journal Article] Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis2009
Author(s)
Li K, Mandai M, Hamanishi J, Matsumura N, Suzuki A, Yagi H, Yamaguchi K, Baba T, Fujii S, Konishi I.
-
Journal Title
Cancer Immunol Immunother 58
Pages: 641-52
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
[Journal Article] Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women2007
Author(s)
Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, Hatae M, Kodama S, Saito T, Terakawa N, Yaegashi N, Hiura M, Sakamoto A, Tsuda H, Fukunaga M, Kamura T.
-
Journal Title
J Clin Oncol. 25
Pages: 2798-803
Peer Reviewed
-
-
-
[Journal Article] Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivity2007
Author(s)
Baba T, Mori S, Matsumura N, Kariya M, Murphy SK, Kondoh E, Kusakari T, Kuroda H, Mandai M, Higuchi T, Takakura K, Fukuda MN, Fujii S.
-
Journal Title
Biochem Biophys Res Commun 360
Pages: 363-9
Peer Reviewed
-
[Journal Article] Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma2007
Author(s)
Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M, Katsuyama Y, Melillo G, Konishi I.
-
Journal Title
Hum Pathol 38
Pages: 1310-20
Peer Reviewed
-
-
-